The FDA has warned that ketamine and compounded ketamine products aren’t approved to treat any psychiatric disorder. This means that they haven’t been verified to generally be Safe and sound or productive. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, https://joanh666fvj4.plpwiki.com/user